Clinical Features, P16 Over-Expression and Overall Survival in Patients with Oral Tongue Squamous Cell Carcinoma
Lanwei Guo,Yulin Yin,Peng Li,Xiaojun Zhang,Defeng Chen,Yang Liu,Jian Wang,Kai Wang,Yiming Zhu,Qing Lv,Xiaoyu Wang
DOI: https://doi.org/10.2139/ssrn.3491892
2019-01-01
SSRN Electronic Journal
Abstract:Background: Prevalence of oral tongue squamous cell carcinoma (OTSCC) is increasing with an invasive clinical behavior with a relatively lower prognosis.Objectives The focus of the research was to investigate the clinical features of OTSCC patients and p16 overexpression associated with overall survival (OS).Methods: We retrospectively collected one hundred and twenty-three patients diagnosed with OTSCC from clinical records. Kaplan–Meier technique was utilized for deducing OS while Log-Rank test was integrated in assessment of the differences between variables. The effects of various prognostic factors on OS were analyzed by the multivariable Cox regression model.Results: A total of 57 deaths were observed, after an average follow-up of 5.3 years. Overall, the 5-year OS was 65.57%. In multivariable analysis, p16(+) (95% CI=0.15-0.83, HR=0.35, P=0.018) confirmed its role as an independent prognostic factor associated with an reduced risk of OS and T4 stage (HR=4.76, 95% CI=2.30-9.93, P<0.001), N1-2 stage (HR=3.36, 95% CI=1.88-6.03, P<0.001), M1 stage (HR=4.15, 95% CI=1.82-9.48, P=0.001), III-IV stage (HR=5.10, 95% CI=2.75-9.45, P<0.001) assured their role as independent prognostic aspects related to high risk in OS.Conclusions: Our results showed the significance of p16 expression in predicting OTSCC prognosis.Funding Statement: This study was supported by the National Natural Science Foundation of China (No. 81703298).Declaration of Interests: All authors disclose no conflicts of interest.Ethics Approval Statement: The authors of this study sought approval of ethics committee of Henan Cancer Hospital and the Chinese Academy of Medical Sciences (CAMS).